NASDAQ:ENTA - Enanta Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$99.87 -3.28 (-3.18 %)
(As of 02/19/2019 10:06 AM ET)
Previous Close$103.15
Today's Range$99.04 - $105.90
52-Week Range$64.08 - $127.77
Volume6,656 shs
Average Volume286,860 shs
Market Capitalization$1.94 billion
P/E Ratio28.30
Dividend YieldN/A
Beta1.27

Analyst Ratings

Enanta Pharmaceuticals (NASDAQ:ENTA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Enanta Pharmaceuticals in the last 12 months. Their average twelve-month price target is $102.60, suggesting that the stock has a possible upside of 2.73%. The high price target for ENTA is $133.00 and the low price target for ENTA is $80.00. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.292.332.33
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $102.60$102.60$108.25$108.25
Price Target Upside: 2.73% upside38.93% upside20.30% upside20.30% upside

Enanta Pharmaceuticals (NASDAQ:ENTA) Consensus Price Target History

Price Target History for Enanta Pharmaceuticals (NASDAQ:ENTA)

Enanta Pharmaceuticals (NASDAQ:ENTA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/13/2018Berenberg BankInitiated CoverageHold ➝ Hold$80.00HighView Rating Details
11/27/2018OppenheimerSet Price TargetHold$100.00HighView Rating Details
8/8/2018UBS GroupDowngradeOutperform ➝ Market PerformHighView Rating Details
7/31/2018JMP SecuritiesReiterated RatingBuy$120.00LowView Rating Details
6/6/2018Roth CapitalInitiated CoverageBuy$133.00HighView Rating Details
4/4/2018Royal Bank of CanadaReiterated RatingHold$80.00LowView Rating Details
2/8/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralHighView Rating Details
8/8/2017Robert W. BairdBoost Price TargetNeutral$27.00 ➝ $36.00MediumView Rating Details
(Data available from 2/19/2017 forward)
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel